Molina Healthcare, Inc.
$153.28
▲
1.51%
2026-04-22 10:12:13
www.molinahealthcare.com
NYQ: MOH
Explore Molina Healthcare, Inc. stock price, valuation, financial statements, dividend history, analyst estimates, and long-term business fundamentals on StockSifting.
Market Cap
$8.02 B
Current Price
$153.28
52W High / Low
$333.22 / $121.06
Stock P/E
17.21
Book Value
$79.78
Dividend Yield
—
ROCE
9.53%
ROE
11.02%
Face Value
—
EPS
$8.92
Exp Qtr EPS
—
Sector
Healthcare
Industry
Healthcare Plans
Employees
19,000
Beta
0.55
Debt / Equity
99.44
Current Ratio
1.69
Quick Ratio
1.69
Forward P/E
16.85
Price / Sales
0.17
Enterprise Value
$3.3 B
EV / EBITDA
3.66
EV / Revenue
0.08
Rating
Hold
Target Price
$151.06
EPS Forecast (FY)
—
Pros
- Short-term liquidity looks comfortable.
- Valuation is not stretched on P/E basis.
Cons
- Operating margin is thin.
- Net margin is relatively low.
Sift Stocks
| S.No. | Name | Price | P.E. | Market Cap | Div Yld % | ROCE | ROE | 52Week High/ Low | Book Value |
|---|---|---|---|---|---|---|---|---|---|
| 1. | Progyny, Inc. | $18.64 | 24.25 | $1.42 B | — | 15.79% | 12.48% | $28.75 / $16.1 | $6.24 |
| 2. | UnitedHealth Group Incorporated | $354.97 | 26.8 | $323.02 B | 2.73% | 9.74% | 12.54% | $489.79 / $234.6 | $103.87 |
| 3. | The Cigna Group | $279.79 | 12.61 | $73.76 B | 2.24% | — | 15.13% | $350 / $239.51 | $158.32 |
| 4. | Humana Inc. | $216 | 21.97 | $26.04 B | 1.68% | — | 7.04% | $315.35 / $163.11 | $146.42 |
| 5. | Clover Health Investments, Corp. | $2.23 | — | $1.15 B | — | -25.75% | -26.33% | $3.92 / $1.58 | $0.59 |
| 6. | Centene Corporation | $39.26 | — | $19.34 B | — | -0.78% | -28.68% | $64.15 / $25.08 | $40.58 |
| 7. | CVS Health Corporation | $77.63 | 55.78 | $99.22 B | 3.47% | 6.3% | 2.29% | $85.15 / $58.35 | $59.18 |
Quarterly Results
Figures shown in M / B
| Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | |
|---|---|---|---|---|---|
| Sales | 11.38 B | 11.48 B | 11.43 B | 11.15 B | 10.5 B |
| Operating Profit | -162 M | 137 M | 373 M | 433 M | 380 M |
| Net Profit | -160 M | 79 M | 255 M | 298 M | 251 M |
| EPS in Rs | -3.07 | 1.52 | 4.9 | 5.72 | 4.82 |
Profit & Loss
Figures shown in M / B
| 2025 | 2024 | 2023 | 2022 | |
|---|---|---|---|---|
| Sales | 45.43 B | 40.65 B | 34.07 B | 31.97 B |
| Operating Profit | 781 M | 1.71 B | 1.57 B | 1.38 B |
| Net Profit | 472 M | 1.18 B | 1.09 B | 792 M |
| EPS in Rs | 9.06 | 22.63 | 20.94 | 15.2 |
Balance Sheet
Figures shown in M / B
| 2025 | 2024 | 2023 | 2022 | |
|---|---|---|---|---|
| Total Assets | 15.56 B | 15.63 B | 14.89 B | 12.31 B |
| Total Liabilities | 11.49 B | 11.13 B | 10.68 B | 9.35 B |
| Equity | 4.07 B | 4.5 B | 4.21 B | 2.96 B |
| Current Assets | 12.44 B | 12.77 B | 12.54 B | 10.08 B |
| Current Liabilities | 7.37 B | 7.9 B | 8.17 B | 6.86 B |
Cash Flow
Last available yearly cash flow history
| 2025 | 2024 | 2023 | 2022 | |
|---|---|---|---|---|
| Operating CF | -535 M | 644 M | 1.66 B | 773 M |
| Investing CF | 312 M | -464 M | -744 M | -790 M |
| Financing CF | -170 M | -347 M | -58 M | -441 M |
| Free CF | -636 M | 544 M | 1.58 B | 682 M |
| Capex | -101 M | -100 M | -84 M | -91 M |
5Y Margin & Growth History
Last 5 year derived history from yfinance annual statements
| 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|
| Revenue Growth % | 19.31% | 6.56% | — | — |
| Earnings Growth % | 8.07% | 37.75% | — | — |
| Profit Margin % | 2.9% | 3.2% | 2.48% | — |
| Operating Margin % | 4.2% | 4.62% | 4.32% | — |
| Gross Margin % | 11.65% | 12.72% | 12.28% | — |
| EBITDA Margin % | 4.66% | 5.12% | 4.22% | — |
Dividend & Split History
Latest dividend and stock split events stored from yfinance
Dividend History
No dividend history available.
Stock Splits
No stock split history available.